
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. Our proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh OShea, Ph.D., of the Salk Institute. It is designed to address key limitations of first- and second-generation oncolytic viruses
Iconovir bio operates in the Biotechnology research industry.
Iconovir bio's revenue is 1m - 10m
Iconovir bio has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.